L. Roy Papp & Associates LLP Sells 3,607 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

L. Roy Papp & Associates LLP decreased its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 151,007 shares of the exchange traded fund’s stock after selling 3,607 shares during the quarter. SPDR S&P Biotech ETF comprises about 1.6% of L. Roy Papp & Associates LLP’s investment portfolio, making the stock its 18th largest position. L. Roy Papp & Associates LLP’s holdings in SPDR S&P Biotech ETF were worth $13,600,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. Golden State Wealth Management LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter valued at about $29,000. Avior Wealth Management LLC grew its position in SPDR S&P Biotech ETF by 393.6% in the fourth quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after acquiring an additional 307 shares in the last quarter. Tidemark LLC increased its stake in SPDR S&P Biotech ETF by 101.5% during the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after acquiring an additional 199 shares during the last quarter. Quintet Private Bank Europe S.A. purchased a new stake in SPDR S&P Biotech ETF during the third quarter valued at approximately $40,000. Finally, ORG Wealth Partners LLC bought a new stake in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at approximately $44,000.

SPDR S&P Biotech ETF Stock Performance

Shares of SPDR S&P Biotech ETF stock opened at $89.05 on Wednesday. The stock has a market cap of $6.79 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The stock has a 50 day moving average price of $92.23 and a 200-day moving average price of $96.30. SPDR S&P Biotech ETF has a one year low of $81.14 and a one year high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.